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ABSTRACT
Objective: Hopelessness is an important construct in
psychosocial epidemiology, but there is great pressure
on the length of questionnaire measures in large-scale
population and clinical studies. We examined the
validity and test–retest reliability of two brief measures
of hopelessness, an existing negatively worded two-
item measure of hopelessness (Brief-H-Neg) and a
positively worded version of the same instrument
(Brief-H-Pos).
Design: Cohort study.
Setting: Control arm of the UK Collaborative Trial of
Ovarian Cancer Screening.
Participants: A non-clinical research-based sample of
5000 postmenopausal women selected from 56 512
participants.
Primary and secondary outcome measures:
Spearman’s rank correlation of brief measures of
hopelessness with the Beck Hopelessness Scale (BHS).
Spearman’s rank correlation with the Centre for
Epidemiological Studies Depression Scale (CES-D) and
change in mean score on repeat testing.
Methods: Two short hopelessness measures, a
negatively worded brief measure of hopelessness
(Brief-H-Neg) and a positively worded brief measure of
hopelessness (Brief-H-Pos), were administered by
postal questionnaire to 5000 women together with the
20-item BHS and 20-item CES-D. The Brief-H-Neg and
Brief-H-Pos were readministered to 500 women after a
2-week interval.
Results: 2413 postmenopausal women (mean age
68.9 years) completed the questionnaire. The Brief-H-
Neg and Brief-H-Pos correlated 0.93 and 0.87 with
the BHS after correction for attenuation and their
association with the CES-D mirrored that seen with the
BHS (Spearman’s rank correlation 0.88 and 0.68,
respectively). There was no change in mean scores on
the two measures with repeat testing in the 433
women who completed them and test–retest reliability
was good (intraclass correlations Brief-H-Neg 0.67 and
Brief-H-Pos 0.72).
Conclusions: These findings provide support for the
validity of the Brief-H-Neg and Brief-H-Pos. These brief
measures are likely to be useful in large population
studies assessing hopelessness.
Trial registration number: NCT00058032.
INTRODUCTION
Hopelessness is the subjective appraisal of
negative expectations about the occurrence
of highly valued outcomes coupled with the
sense that one lacks control over desired
events in the future.1 Hopelessness has been
related to the onset and prognosis of mental
and physical health outcomes including the
development of depression,1 suicidal idea-
tion,2 hypertension,3 subclinical atheroscler-
osis,4 5 adaptation following acute cardiac
events6 and progression of carotid athero-
sclerosis.4 In the psycho-oncology literature,
hopelessness has been found to predict prog-
nosis in various cancers including breast and
haematological cancers,7 8 although the evi-
dence is not consistent.
Hopelessness has been measured in clin-
ical and population research in a variety of
ways including systematic interviews9 and vali-
dated psychometric measures such as the
Beck Hopelessness Scale (BHS)10 and the
Mental Adjustment to Cancer scale.11 There
is great pressure in large-scale population
studies on questionnaire size due to the
volume of clinical and demographic variables
that must be collected. Everson et al12
devised a two-item measure of hopelessness
which has been used in a number of cardio-
vascular studies.3 4 12 The reliability of this
instrument and its relationship with standard
measures has not been established. An
Strengths and limitations of this study
▪ The strength of this study is the large sample
size.
▪ Limitations include generalisability of the results
beyond older women and the modest response
rate.
▪ It is not known whether the positively phrased
measure of hopelessness is associated with less
participant distress compared to the negatively
phrased measure.
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additional issue concerns the negative valence of the
items (eg, “The future seems to me to be hopeless and I
can’t believe that things are changing for the better”).
In preliminary work for the large study in which this
research is embedded, some respondents found these
items upsetting and this has been conﬁrmed by others.13
We devised a positively worded two-item version. We
compared both brief measures with established mea-
sures of hopelessness and depressive symptoms in a
large population sample, and assessed their reliability.
METHODS
Participants
Five thousand participants were selected from 56 512
postmenopausal women in the control arm of the UK
Collaborative Trial of Ovarian Cancer Screening
(UKCTOCS,14 ISRCTN22488978). The mean age of
women invited was 69.6±6.1 years (range 57–85).
Procedure
A postal questionnaire comprised of measures of hope-
lessness and depression was sent to 5000 women (Time 1,
T1). After a 2-week interval (Time 2, T2), 500 respon-
dents were asked to repeat the Brief-H-Neg (n=250) or
the Brief-H-Pos (n=250) to assess test–retest reliability.
Selection of the retest cohort was staggered based on the
date of T1 questionnaire return, as early and late respon-
ders may differ on levels of hopelessness or depression.15
Measures
The Brief-H-Neg is a two-item measure of hopelessness
comprised of negatively valenced statements: “The
future seems to me to be hopeless and I can’t believe
that things are changing for the better”; “I feel that it is
impossible to reach the goals I would like to strive for.”12
Everson et al selected these from a battery of psycho-
social measures used in the Kuopio Ischemic Heart
Disease study, deﬁning hopelessness as negative expect-
ancies about oneself and the future. Respondents indi-
cate agreement on a ﬁve-point scale (range 2–10),
higher scores indicate higher hopelessness (see online
supplementary appendix A).
The Brief-H-Pos was derived by reversing the tone of
the Brief-H-Neg statements from negative to positive and
reverse scoring: “The future seems to me to be hopeful
and I believe that things are changing for the better”;
“I feel that it is possible to reach the goals I would like
to strive for” (see online supplementary appendix B).
The BHS is a validated 20-item true–false measure
assessing current levels of hopelessness.10 Items include
pessimistic statements (“There’s no use in really trying to
get something I want because I probably won’t get it”)
and optimistic ones (“I look forward to the future with
hope and enthusiasm”). Pessimistic ratings are summed
(range 0–20); higher scores indicate higher hopelessness.
The Centre for Epidemiological Studies Depression
Scale (CES-D) is a validated 20-item measure of
depressive symptoms.16 Responses are based on the fre-
quency of occurrence during the past week using a four-
point scale (range 0–60); higher scores indicate more
frequent symptoms of depression.
Analyses
Internal consistency was based on coefﬁcient α17 with α
cut-off points 0.70–0.79 described as adequate and ≥0.80
as high.18 Stability was evaluated using test–retest reliabil-
ity based on the intraclass correlation coefﬁcient (ICC)
with cut-offs ≤0.40 for poor, 0.41–0.59 fair, 0.60–0.74 good,
≥0.75 excellent.19 The estimated variance components
derived from a one-way random effects model were used
to calculate ICCs.20 The relationship between study mea-
sures was assessed using Spearman’s rank correlations
(CIs were estimated using bootstrapping with 1000 itera-
tions).21 To estimate the strength of correlations
between study measures, a correction for attenuation
arising from measurement error was applied:
rxy ¼ rxy=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðrxx:ryyÞ
p
,22 23 where ρxy=true correlation
between x and y, rxy=observed correlation between x and
y, rxx=estimated reliability of x and ryy=estimated reliabil-
ity of y. We used published test–retest reliability estimates
for rxx and ryy: BHS 0.69
24 and CES-D 0.67.16 In the
absence of published test–retest data for the
Brief-H-Neg/Brief-H-Pos, we used the ICCs reported in
this study. Data were analysed using STATAV.12.1.
RESULTS
Sample characteristics
The questionnaire was returned by 2413 women (48.3%;
T1; table 1). Respondents reported signiﬁcantly higher
Table 1 Description of respondents’ characteristics
Respondents (N=2413)
Age in years (mean±SD) 68.9±5.9 (range 57–84)
Ethnicity n (%)
White 2376 (98.7)
Black 11 (0.5)
Asian 7 (0.3)
Other 14 (0.6)
Unknown 5 (0.2)
Education n (%)
Higher (university,
professional)
819 (33.9)
Some (O’ level, A’ level,
clerical)
955 (39.6)
None 610 (25.3)
Unknown 29 (1.2)
Hopelessness (mean±SD)
Brief-H-Neg 4.42±2.21 (n=2402)
Brief-H-Pos 4.74±1.85 (n=2393)
BHS 4.81±4.49 (n=2400)
Depression (mean±SD)
CES-D 12.44±10.39 (n=2395)
BHS, Beck Hopelessness Scale; CES-D, Centre for
Epidemiological Studies Depression Scale.
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levels of education than non-respondents, were younger
and more likely to be Caucasian (differences were not
clinically signiﬁcant, due to their small magnitude). One
hundred and ﬁfteen respondents (4.77%) scored CES-D
≥16/60, a cut-off indicative of clinically signiﬁcant
depressive symptomatology, suggesting that this cohort is
not unusually depressed.
Concurrent validity
The Brief-H-Neg and Brief-H-Pos measures correlated
well with the BHS and mirrored the positive association
seen between the BHS and the CES-D (table 2).
Stability
In total, 433/497 (87.1%) women completed the
Brief-H-Neg (n=221) or Brief-H-Pos (n=212) on two
occasions. Brief-H-Neg, T1 M=4.64±1.74 (n=248), T2
M=4.29±2.39 (n=221); Brief-H-Pos, T1 M=4.61±1.878
(n=249), T2 M=4.57±1.96 (n=212). The short-term test–
retest reliability of both measures was good: Brief-H-Neg
ICC=0.67 (95% CI 3.98 to 4.49) and Brief-H-Pos
ICC=0.72 (95% CI 4.39 to 4.83).
Reliability
All study measures demonstrated good internal consist-
ency: Brief-H-Neg α 0.80, Brief-H-Pos α 0.77, BHS α
0.89, CES-D α 0.90. α for the Brief-H-Neg and
Brief-H-Pos was lower than the longer BHS and CES-D
(α is known to rise as the number of items increases).
DISCUSSION
A brief measure is needed to examine the role of hope-
lessness on mental and physical health outcomes in
large population studies. We examined the validity and
reliability of two brief measures of hopelessness in a
large non-clinical sample, one negatively valenced
(Brief-H-Neg) and one positively valenced (Brief-H-Pos).
Both were shown to correlate strongly with the longer
BHS and mirror the positive correlation seen between
the BHS and a measure of depression, providing evi-
dence of concurrent validity, with adequate internal con-
sistency and test–retest reliability.
The sizes of the 2-week retest correlations for the brief
measures reported in our non-clinical sample (0.67 and
0.72) are similar to those reported for the BHS in a
sample of university undergraduates over a 3-week retest
interval (0.67, female students) or a 10-week interval
(0.75).25 26 Studies assessing the retest reliability of
hopelessness instruments have reported varying retest
intervals. Hopelessness may be conceptualised as a tem-
porary mood state reﬂecting a person’s response to chal-
lenging circumstances, or a more enduring trait
reﬂecting a habitual outlook on many aspects of life.27
Most commonly used measures of hopelessness, includ-
ing the BHS, do not distinguish between state and trait
hopelessness. If hopelessness is an enduring trait, mea-
sures of hopelessness would be expected to have high
test–retest reliability. A measure that does address the
state versus trait distinction, the State-Trait Hopelessness
Scale, has reported retest correlations of state and trait
hopelessness over a 6-week interval (state 0.65, trait
0.74) and over a 6-month interval (state 0.61, trait 0.78)
in hospitalised patients with coronary heart disease.28
Again, the sizes of these retest correlations are not dis-
similar to those seen in the brief measures reported in
our study after a 2-week interval.
The selection of a measure is determined to an extent
by the practical context of the investigation. Very brief
measures necessarily sacriﬁce some level of detail com-
pared with their longer counterparts.29 A pooled analysis
and meta-analysis of 22 studies involving ultrashort
(one-item, two-item, three-item or four-item) tests con-
cluded that two-item and three-item measures of depres-
sion identify 8 out of 10 cases in primary care settings,
albeit at the expense of a high false-positive rate.30 This
makes them inappropriate diagnostic tests for clinical
decision-making, but suitable as screening tools in
primary care as well as in population cohort research
where participants have to complete a number of demo-
graphic and clinical questions in addition to psycho-
logical measures.31
Our data suggest that while 2-item measures of hope-
lessness may not have the detail of the 20-item BHS
measure, they do have adequate reliability to be used in
large population-based studies. The reduced burden on
participants may encourage a high response rate. The
ﬁve-point Likert response scales of the Brief-H-Neg and
Brief-H-Pos provide a reasonable range of scores to work
with. However, if information on the hypothesised affect-
ive, motivational and cognitive aspects of hopelessness is
required in order, for example, to target a therapeutic
intervention, the 20-item BHS would be more suitable,
because a total score for each dimension can be derived
from the summed individual items of the scale.10
The results of this study provide preliminary support
for the construct validity of both brief measures of hope-
lessness but further testing of their construct validity is
required, along with tests of their predictive validity on
physical and mental health outcomes. It would be
helpful to examine the psychometric properties of both
brief measures in a psychiatric sample where higher
levels of hopelessness are expected, such as a group of
hospitalised patients who have attempted suicide.32
There is good evidence that hopelessness is associated
with suicidal ideation and is recognised as a better
Table 2 Correlation between measures of hopelessness
and depression
Brief-H-Neg (n) Brief-H-Pos (n) BHS (n)
BHS 0.93 (2393) 0.87 (2384)
CES-D 0.88 (2379) 0.68 (2392) 0.87 (2379)
BHS, Beck Hopelessness Scale; CES-D, Centre for
Epidemiological Studies Depression Scale.
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predictor for suicidal intent than depression.33
Moreover, brief measures of hopelessness derived from
the BHS, including a four-item scale and, to a lesser
extent, a single item, have been shown to perform as
well as the 20-item BHS in identifying people with sui-
cidal ideation.34 The predictive validity for the
Brief-H-Neg on physical health outcomes has been
shown in studies exploring the relationship between
hopelessness and disease incidence and mortality, and
this remains to be addressed for the Brief-H-Pos.3–5 12
There are some limitations to this study. First, the
sample of older women limits the generalisability of the
results. It would be useful to validate the Brief-H-Neg
and Brief-H-Pos in a general population sample and to
generate normative data, as has been shown for two-item
measures of depression (Patient Health Questionnaire,
PHQ-2) and anxiety (Generalized Anxiety Disorder
Scale, GAD-2).35 36 Second, the response rate of 48.3%
is modest, although importantly there was no evidence
of bias between responders and non-responders and the
sample of responders is large. It is perhaps unsurprising
that many of the women invited from the control arm of
an Ovarian Cancer Screening study were not motivated
to take part in this nested study assessing brief measures
of hopelessness. Finally, we did not directly test the
assumption that those suffering from low mood may
ﬁnd it difﬁcult to be confronted with the negatively
phrased questions of the Brief-H-Neg compared with the
positively phrased Brief-H-Pos.
CONCLUSION
Everson et al’s negatively valenced measure of hopeless-
ness (Brief-H-Neg) and the positively valenced measure
(Brief-H-Pos) [which was] developed as a potentially less
stressful measure in health research, have been shown to
be valid and reliable measures of hopelessness. Further
testing to verify their construct validity is warranted.
Meanwhile, the ﬁndings suggest that these brief measures
are ﬁt for purpose in large-scale population studies inves-
tigating the association of hopelessness and health out-
comes. Evidence of a consistent association with mortality
in such studies would add impetus to the search for inter-
ventions that can modify the risk.
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